GE HealthCare Technologies EPS GEHC
Diluted earnings per share by quarter and over the last twelve months, from 2022.
- Last 12 months, to Jun 30, 2026
- $4.36
- Latest quarter, Q2 FY26
- $1.24
- +17% on a year earlier
- Fiscal year 2025
- $4.56
- +5% on the year before
GE HealthCare Technologies' earnings per share was $4.36 over the twelve months to Jun 30, 2026, down 11% on a year earlier.
In its latest quarter, Q2 FY26, it was $1.24, up 17% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $4.56 | +5% |
| FY2024 | $4.33 | +43% |
| FY2023 | $3.02 | −28% |
| FY2022 | $4.22 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $1.24 | +17% | $4.36 | |
| Q1 FY26 | $0.85 | −31% | $4.18 | |
| Q4 FY25 | $1.29 | −18% | $4.56 | |
| Q3 FY25 | $0.98 | −4% | $4.84 | |
| Q2 FY25 | $1.06 | +14% | $4.88 | |
| Q1 FY25 | $1.23 | +52% | $4.75 | |
| Q4 FY24 | $1.57 | +78% | $4.33 | |
| Q3 FY24 | $1.02 | +24% | $3.64 | |
| Q2 FY24 | $0.93 | +2% | $3.44 | |
| Q1 FY24 | $0.81 | +98% | $3.42 | |
| Q4 FY23 | $0.88 | −28% | $3.02 | |
| Q3 FY23 | $0.82 | −23% | $3.36 |
Against its peers
Companies in Medical - Devices nearest GE HealthCare Technologies' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| GEHCGE HealthCare Technologies | $4.36 | −11% a year |
| DXCMDexCom | $2.52 | +76% a year |
| EWEdwards Lifesciences | $1.74 | −75% a year |
| ZBHZimmer Biomet | $4.11 | +0% a year |
| BSXBoston Scientific | $2.47 | +47% a year |
| SYKStryker | $9.65 | +28% a year |
| MDTMedtronic | $4.07 | +12% a year |
| ABTAbbott Laboratories | $2.68 | −66% a year |
| LIVNLivaNova | $3.39 | |
| ITGRInteger | $3.66 | +61% a year |
| Peer median | $3.39 |
Where GE HealthCare Technologies ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on GE HealthCare Technologies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.